Examiner: AZPURU, CARLOS A

Tech Center 3700 • Art Units: 1612 1615 1616 1617 3774

This examiner grants 84% of resolved cases

Performance Statistics

83.8%

Allow Rate

+13.8% vs TC avg

1,316

Total Applications

+10.6%

Interview Lift

964

Avg Prosecution Days

Based on 1291 resolved cases, 2023–2026

2.7%

§101 Eligibility

20.0%

§102 Novelty

24.5%

§103 Obviousness

30.4%

§112 Clarity

App #	Title	Status	Assignee
18539045	MEDICAL COMPOSITIONS BASED ON CROSSLINKABLE HYDROPHILIC POLYMERS	Non-Final OA	Boston Scientific Scimed, Inc.
18443360	COSMETIC INK COMPOSITION COMPRISING A SURFACE TENSION MODIFIER	Non-Final OA	The Procter & Gamble Company
18599800	USE OF ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION	Non-Final OA	Allergan, Inc.
18431725	TREATMENT OF SEPSIS AND SEPTIC SHOCK	Final Rejection	COMBIOXIN SA

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.